Anteris Technologies Global (AVR) Stock Price, News & Analysis

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Key Stats

• Today's Range: $3.73 to $4.30
• 50-Day Range: $2.90 to $4.15
• 52-Week Range: $2.34 to $8.79
• Volume: 154,995 shs
• Average Volume: 115,837 shs
• Market Capitalization: $149.65 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.50
• Consensus Rating: Buy

AVR Stock Analysis - Frequently Asked Questions

How have AVR shares performed this year?

Anteris Technologies Global's stock was trading at $5.58 at the beginning of the year. Since then, AVR stock has decreased by 25.6% and is now trading at $4.15.

How were Anteris Technologies Global's earnings last quarter?

Anteris Technologies Global Corp. (NASDAQ:AVR) issued its earnings results on Monday, August, 11th. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.53) by $0.05. The company earned $0.62 million during the quarter, compared to analysts' expectations of $0.58 million.

When did Anteris Technologies Global IPO?

Anteris Technologies Global (AVR) raised $89 million in an initial public offering (IPO) on Friday, December 13th 2024. The company issued 14,800,000 shares at $6.00 per share.

Who are Anteris Technologies Global's major shareholders?

Anteris Technologies Global's top institutional shareholders include L1 Capital Pty Ltd (7.80%), Sio Capital Management LLC (5.10%), Perceptive Advisors LLC (4.73%) and Nantahala Capital Management LLC (4.70%).

How do I buy shares of Anteris Technologies Global?

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/11/2025
• Today: 8/22/2025
• Next Earnings (Estimated): 11/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AVR
• Previous Symbol: NASDAQ:AVR
• CIK: 2011514
• Web: N/A
• Phone: (651) 493-0606
• Fax: N/A
• Employees: 138
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Anteris Technologies Global: $16.50
• High Price Target: $22.00
• Low Price Target: $9.00
• Potential Upside/Downside: +297.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.41
• Quick Ratio: 2.38

Sales & Book Value

• Annual Sales: $2.70 million
• Price / Sales: 55.43
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.67 per share
• Price / Book: 6.19

Miscellaneous

• Outstanding Shares: 36,060,000
• Free Float: N/A
• Market Cap: $149.65 million
• Optionable: N/A
• Beta: N/A